Summary
- Current Price
- As of today, CGEM price is $21.70, down -3.98% on
- Current Price All-Time High
- CGEM price is currently -63.74% below its historical high of $59.85 set on
- Market Cap
- CGEM current market cap is $1B, up +196.66% over the past 365 days
- Revenue
- CGEM current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for CGEM is on
Profile
| Metric | Value |
|---|---|
| Full Name | Cullinan Therapeutics, Inc. |
| Ticker | NASDAQ: CGEM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | cullinantherapeutics.com |
| Employees | 111 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $21.70 | |
| Price, 1D Change | -3.98% | |
| $1B | ||
| - | ||
| - | ||
| 1.28 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$3.72 | ||
| EPS, 1Y Change | -19.62% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$3.72 | ||
| EPS Estimate | -$3.17 | N/A |
| EPS Est. Change | +15.00% | N/A |
| $0.00 | ||
| Revenue Estimate | $13.88M | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $21.70 | |
| Price Target | $30.00 | - |
| Price Tgt. Change | +38.25% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.94 | -$3.11 | -5.93% | |
| -$3.62 | -$3.72 | -2.90% | |
| -$3.17 | N/A | +15.00% | |
| -$2.71 | N/A | +27.21% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $6.12M | $0.00 | -100.00% | |
| $13.88M | N/A | - | |
| $38.23M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $21.70 | |
| $14.28 | ||
| $18.64 | ||
| $14.93 | ||
| $18.78 | ||
| $1.31 | ||
| 1.28 | ||
| $1.15 | ||
| 61.67 | ||
| 61.45% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$3.72 | ||
| -$311.00K | ||
| - | ||
| -$241.65M | ||
| - | ||
| -$219.88M | ||
| - | ||
| -$241.34M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.01 | ||
| 10.25 | ||
| 10.25 | ||
| - | ||
| - | ||
| 17.13 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 4.14 | ||
| -4.52 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $408.73M | ||
| $377.90M | ||
| $449.14M | ||
| $386.76M | ||
| $40.41M | ||
| $37.74M | ||
| $2.68M | ||
| $780.00K | ||
| $841.00K |
Expenses
| Metric | Value | Date |
|---|---|---|
| $219.88M | ||
| $241.34M | ||
| $311.00K | ||
| $54.25M | ||
| $311.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$175.75M | ||
| $179.99M | ||
| $1.09M | ||
| $49.00K | ||
| -$175.80M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| Wedbush | → | |
| BTIG | → | |
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| Wedbush | → | |
| BTIG | → | |
| HC Wainwright & Co. | → | |
| BTIG | → |
Analyst sentiment
Institutional ownership
No data
Screeners with CGEM
FAQ
- What is the ticker symbol for Cullinan Therapeutics, Inc.?
- The ticker symbol for Cullinan Therapeutics, Inc. is NASDAQ:CGEM
- Does Cullinan Therapeutics, Inc. pay dividends?
- No, Cullinan Therapeutics, Inc. does not pay dividends
- What sector is Cullinan Therapeutics, Inc. in?
- Cullinan Therapeutics, Inc. is in the Healthcare sector
- What industry is Cullinan Therapeutics, Inc. in?
- Cullinan Therapeutics, Inc. is in the Biotechnology industry
- What country is Cullinan Therapeutics, Inc. based in?
- Cullinan Therapeutics, Inc. is headquartered in United States
- When did Cullinan Therapeutics, Inc. go public?
- Cullinan Therapeutics, Inc. initial public offering (IPO) was on January 8, 2021
- Is Cullinan Therapeutics, Inc. in the S&P 500?
- No, Cullinan Therapeutics, Inc. is not included in the S&P 500 index
- Is Cullinan Therapeutics, Inc. in the NASDAQ 100?
- No, Cullinan Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Cullinan Therapeutics, Inc. in the Dow Jones?
- No, Cullinan Therapeutics, Inc. is not included in the Dow Jones index
- When was Cullinan Therapeutics, Inc. last earnings report?
- Cullinan Therapeutics, Inc.'s most recent earnings report was on August 6, 2026
- When does Cullinan Therapeutics, Inc. report earnings?
- The next expected earnings date for Cullinan Therapeutics, Inc. is November 5, 2026
Data Sources & References
- CGEM Official Website cullinantherapeutics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1789972/000119312526099362/0001193125-26-099362-index.htm
- CGEM Profile on Yahoo Finance finance.yahoo.com/quote/CGEM
- CGEM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cgem